Research Institute of the Ï㽶ÊÓƵ Health Centre (RI-MUHC) /newsroom/taxonomy/term/11331/all en Experts: Halloween 2024  /newsroom/channels/news/experts-halloween-2024-360667 <p><!-- x-tinymce/html --></p> <p>With Halloween approaching, Ï㽶ÊÓƵ experts are available to offer insights on a range of related topics.  </p> Thu, 24 Oct 2024 20:56:07 +0000 keila.depape@mcgill.ca 314752 at /newsroom Using AI to predict recurring lung cancer /newsroom/channels/news/using-ai-predict-recurring-lung-cancer-345862 <p>Lung cancer is the leading cause of cancer-related deaths in Quebec and Canada, killing more individuals than prostate, colon and breast cancers combined. Thanks to tissue samples from almost 500 lung cancer patients, a group of researchers from Ï㽶ÊÓƵ and Université Laval were able to identify <a href="/medhealthsci/channels/news/mcgill-researchers-studies-offer-promise-lung-and-brain-cancer-treatment-345865">those who were likely to have a cancer recurrence and require further treatment post-surgery</a>.</p> Thu, 02 Feb 2023 15:04:56 +0000 claire.loewen@mcgill.ca 289182 at /newsroom McGill and RI-MUHC awarded $5.1 million for infectious disease research /newsroom/channels/news/mcgill-and-ri-muhc-awarded-51-million-infectious-disease-research-343547 <p>New funding of $5.1 million from the Canada Foundation for Innovation (CFI), announced today by the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, will help researchers Marcel Behr, MD, PhD, and Silvia Vidal, PhD, ensure that Canada is better prepared for the next pandemic. This funding is part of the more than $127 million investment being made through the CFI to support upgrades to eight biocontainment facilities across the country as part of its new Biosciences Research Infrastructure Fund (BRIF) program.</p> Wed, 16 Nov 2022 12:56:10 +0000 katherine.gombay@mcgill.ca 288505 at /newsroom Can inhaled corticosteroids alleviate early symptoms of COVID-19? /newsroom/channels/news/can-inhaled-corticosteroids-alleviate-early-symptoms-covid-19-334535 <p>Despite high hopes, a new pan-Canadian study published today in The BMJ suggests that ciclesonide—an inhaled and nasal steroid drug commonly used for asthma and rhinitis—won’t be the treatment to change the course of the pandemic.</p> Tue, 02 Nov 2021 13:37:42 +0000 katherine.gombay@mcgill.ca 283084 at /newsroom